(A): L0-1 in HBeAg-positive patients. (B): L4A-4C in HBeAg-positive patients. (C): L4A-4C in HBeAg-negative patients).</p
A certain proportion of hepatitis B virus (HBV)-infected patients with persistently normal alanine t...
Background: The most important difficulties about management of hepatitis B are still determining th...
Noninvasive biomarkers have been developed to predict hepatitis B virus (HBV)-related fibrosis owing...
<p>Predictive values for advanced liver fibrosis in patients infected with HCV.</p
AbstractObjective: In hepatitis B infection, it is difficult to make a treatment decision in pa...
BACKGROUND:There is no consensus regarding the relationship between HBV DNA and liver fibrosis, and ...
BackgroundThere is no consensus regarding the relationship between HBV DNA and liver fibrosis, and t...
There is no data on the relationship between hepatitis B surface antigen (HBsAg) levels and liver fi...
Comparison of groups with different HBV DNA levels and liver fibrosis and cirrhosis.</p
OBJECTIVE: To determine the relationship between hepatitis B virus (HBV) DNA levels and total histol...
(1) Background: As specialparameters in predicting significant hepatitis activity of hepatitis B e a...
BACKGROUNDS: To optimize management and predict long-term clinical courses in patients with chronic ...
BACKGROUND: Liver biopsy for evaluation of liver fibrosis has several adverse effects, for which rea...
<p>(A–C) correlation between serum HBsAg (log10 IU/ml) and HBV DNA (log10 IU/ml) in 183 patients wit...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
A certain proportion of hepatitis B virus (HBV)-infected patients with persistently normal alanine t...
Background: The most important difficulties about management of hepatitis B are still determining th...
Noninvasive biomarkers have been developed to predict hepatitis B virus (HBV)-related fibrosis owing...
<p>Predictive values for advanced liver fibrosis in patients infected with HCV.</p
AbstractObjective: In hepatitis B infection, it is difficult to make a treatment decision in pa...
BACKGROUND:There is no consensus regarding the relationship between HBV DNA and liver fibrosis, and ...
BackgroundThere is no consensus regarding the relationship between HBV DNA and liver fibrosis, and t...
There is no data on the relationship between hepatitis B surface antigen (HBsAg) levels and liver fi...
Comparison of groups with different HBV DNA levels and liver fibrosis and cirrhosis.</p
OBJECTIVE: To determine the relationship between hepatitis B virus (HBV) DNA levels and total histol...
(1) Background: As specialparameters in predicting significant hepatitis activity of hepatitis B e a...
BACKGROUNDS: To optimize management and predict long-term clinical courses in patients with chronic ...
BACKGROUND: Liver biopsy for evaluation of liver fibrosis has several adverse effects, for which rea...
<p>(A–C) correlation between serum HBsAg (log10 IU/ml) and HBV DNA (log10 IU/ml) in 183 patients wit...
AIM:To evaluate the diagnostic accuracy and clinical utility of the fibrosis index based on the four...
A certain proportion of hepatitis B virus (HBV)-infected patients with persistently normal alanine t...
Background: The most important difficulties about management of hepatitis B are still determining th...
Noninvasive biomarkers have been developed to predict hepatitis B virus (HBV)-related fibrosis owing...